Search

Your search keyword '"Audrey Simonaggio"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Audrey Simonaggio" Remove constraint Author: "Audrey Simonaggio"
19 results on '"Audrey Simonaggio"'

Search Results

1. Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

2. Impact des signatures moléculaires sur le choix du traitement systémique du cancer du rein métastatique

3. BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer

4. Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib

5. Overall survival (OS) and efficacy results of second-line treatment in patients (pts) with metastatic clear cell renal cell carcinoma (mRCC) treated in the randomized phase II BIONIKK trial

6. MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights

7. Preexisting autoantibodies as predictor of immune-related adverse events for advanced solid tumors treated with immune checkpoint inhibitors

8. Immunothérapie des cancers du rein

9. Autres immunothérapies

10. Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments

11. Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a review

12. Future treatment options in metastatic clear cell renal cell carcinoma

13. Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

14. [Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer]

15. Resistance to cancer immunotherapy in metastatic renal cell carcinoma

16. https://cdrjournal.com/article/view/3531

17. Quelle stratégie thérapeutique pour les stades métastatiques ?

18. The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors

19. Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

Catalog

Books, media, physical & digital resources